The role of Epstein-Barr virus (EBV) in the development of sinonasal undifferentiated carcinoma (SNUC) remains unresolved. Reports of EBV-positivity in SNUC may reflect inclusion of lymphoepithelioma-like carcinomas within this group. In addition, SNUC have been incompletely characterized immunohistochemically, and their undifferentiated appearance often requires such ancillary studies to aid in their distinction from other high-grade neoplasms. To address these two issues, 25 cases of SNUC diagnosed between the years 1983 and 1999 were selected from our files. EBER in situ hybridization (ISH) was performed on the paraffin-embedded tissue by using 3 Hlabeled EBER-1 RNA probes. Neoplasms with sufficient tissue (22 of 25) were evaluated immunohistochemically for Ki-67, p53, chromogranin, synaptophysin, placental alkaline phosphatase (PLAP), CD99, carcinoembryonic antigen (CEA), epithelial membrane antigen (EMA), neuron-specific enolase (NSE), and latent membrane protein-1 (LMP-1). The median patient age was 58 years (range, 20-81 years), with a male-to-female ratio of approximately 3:1. The most common tumor location was the nasal cavity (18 cases), followed by the ethmoid and maxillary sinuses. Median survival was 18 months. All 25 tumors were negative for EBER-1 by ISH. Ki-67 was negative in one case, 1+ in nine, 2+ in six, 3+ in five, and 4+ in one. P53 was negative in nine, 1+ in five, 2+ in two, 3+ in none, and 4+ in six. CD99 expression was strongly positive in 3 of 22 (14%) and completely negative in the remainder. Variably intense focal staining for EMA was present in 4 of 22 (18%). NSE faintly stained 4 of 22 (18%). Chromogranin, synaptophysin, PLAP, CEA, and LMP-1 were negative (0 of 22). Our results suggest that EBV does not play a role in the development of SNUC. Strict histologic criteria are necessary to avoid confusion with lymphoepithelioma-like carcinoma or other highgrade malignancies in this region. The finding of occasional CD99-positive cases adds SNUC to the growing list of CD99positive neoplasms.
Sinonasal neoplasms are a biologically heterogeneous group, which often pose a considerable diagnostic challenge. Included in this diverse group of neoplasms is sinonasal undifferentiated carcinoma (SNUC), a uniformly high-grade tumor of the nose and paranasal sinuses composed of small and medium-sized cells, frequently accompanied by extensive necrosis and vascular permeation. Although typically composed of somewhat larger cells, SNUC may be confused with small "blue cell" tumors of the sinonasal region, including melanoma, lymphoma, and olfactory neuroblastoma. These tumors are currently differentiated from SNUC by a combination of microscopic features (e.g., Homer Wright rosettes, neuropil), clinical features including site of origin, and immunophenotype. The close proximity of the sinonasal region to the nasopharynx raises the additional possibility of a destructive undifferentiated nasopharyngeal carcinoma ("lymphoepithelioma") that has extended into the paranasal sinuses or nasal cavity. In such cases, distinction from SNUC has traditionally rested on histologic findings. The universal association of Epstein-Barr virus (EBV) with undifferentiated nasopharyngeal carcinoma suggests that the presence of latent EBV infection may provide a marker for distinguishing nasopharyngeal carcinoma from SNUC. However, several publications have raised the possibility of EBV positivity in SNUC. 10, 11, 14, 15 The aim of this study was to examine a series of stringently defined SNUC for latent EBV infection by using in situ hybridization and to further characterize these rare and aggressive tumors clinically and immunohistochemically.
MATERIALS AND METHODS

Tissue Acquisition and Histopathologic Diagnosis
Twenty-eight cases initially diagnosed as SNUC between the years 1983 and 1999 were collected from the general and consultation files (S.E.M.) of the University of Virginia Medical Center (26 cases) and the Mount Sinai Hospital (2 cases). Each tumor was reviewed by two of the authors (L.A.C., S.E.M.). Twenty-five met the morphologic criteria for SNUC as originally defined by Frierson et al. 6 and had additional tissue available for study. Some clinical, light microscopic, and immunohistochemical features of eight cases in this series have been previously reported. 2, 6, 7 
In Situ Hybridization Studies
The EBV RNA in situ hybridization studies were performed by using an antisense RNA probe to a portion of the EBER-1 RNA as previously described, 8, 22 a region of the EBV genome known to be actively transcribed in latently infected cells. In vitro transcription to generate 3 H-labeled riboprobes was performed as previously described. Four-micron-thick sections were cut from paraffin blocks of zinc-formalin-fixed tissues and mounted on 3-aminopropyltriethoxysilane-coated slides. Sections were deparaffinized, dehydrated, predigested with proteinase K, and then hybridized overnight at a concentration of 0.2 g/mL/Kb complexity of probe. An antisense actin probe also was applied to parallel sections of each case to control for RNA preservation. After stringent washing, detection via autoradiography with a light hematoxylin and eosin counterstain was performed. In each run, known EBV-positive and EBV-negative tissues were included as positive and negative controls. The in situ hybridization results were evaluated by using darkfield microscopy for grain distribution with bright field optics to confirm morphology.
Immunohistochemical Studies
Using the avidin-biotin immunoperoxidase technique described elsewhere, 17 20 The primary antibody was omitted for the negative control. Sections from appropriate tissues containing the desired antigens served as positive con-trols. Antigenic reactions were semiquantitatively scored on the basis of percentage positive cells, as follows: 0% ‫ס‬ 0, 1%-25% ‫ס‬ 1+, 26%-50% ‫ס‬ 2+, 51%-75% ‫ס‬ 3+, and 76%-100% ‫ס‬ 4+.
RESULTS
Clinical Features
The clinical data are summarized in Table 1 . The median patient age was 58 years (range, 20-81 years), with a male-to-female ratio of approximately 3:1. The most common tumor location was the nasal cavity (18 cases), with five of the tumors extending into the ethmoid sinus and one involving the maxillary sinus. Five cases appeared clinically to have arisen in the maxillary sinus. Orbital destruction was found at the time of initial diagnosis in two cases. One tumor exclusively occupied the ethmoid sinus. Despite large, often destructive tumors, most patients presented with either isolated diplopia or minor complaints of sinus congestion. Work histories were available for 12 patients. Employment was diverse and, with the exception of one individual employed in the chrome plating industry and described in our initial study, 6 no obvious employment-related exposures could be identified. Seven of the 12 patients with available histories were known smokers (58%).
No standardized treatment approach has been developed for SNUC. Patients invariably received radiation therapy, to both their tumors and lymph node drainage areas, either as the major modality or in association with surgery. Many received extensive surgical resections, including craniofacial resections in an attempt to completely remove local disease. Lymph node dissections were performed occasionally, primarily in patients with clinically obvious metastases. Variable chemotherapeutic regimens were performed, including treatment of two patients with high-dose chemotherapy and autologous bone marrow transplant.
Follow-up information was available for 16 cases. Local recurrence was found in 9 (56%), and 12 (75%) developed metastatic disease, which in most cases was extensive. Eight patients (50%) had confirmed cervical node involvement, and in one patient, cervical adenopathy was the presenting symptom. Two patients received high-dose chemotherapy and bone marrow transplants and had extended survival, but both eventually died of recurrent disease 9 years after the initial diagnosis. A total of 13 patients died as a result of disease (81%), with a median survival of 18 months. Follow-up durations for the remaining three patients were 7 months, 9 months, and 10 years; the first two of these patients were undergoing treatment for local recurrences at the time of this report. The last is the only long-term disease-free survivor.
Light Microscopic Observations
Sinonasal undifferentiated carcinoma were composed of small to medium-sized cells with large, ovoid nuclei, generally high nuclear-to-cytoplasmic ratios, and correspondingly small amounts of eosinophilic cytoplasm ( Table 2 ). In thin sections, distinct cell borders could be appreciated. Most SNUC showed extensive coagulative necrosis, often with areas of central "comedonecrosis" in larger cell nests ( Fig. 1 ). Nuclear chromatin was usually homogeneous and coarse, although a minority of cases manifested more vesicular chromatin reminiscent of lymphoepithelioma. Although a few SNUC lacked obvious nucleoli, a single prominent nucleolus was typically present. In spite of the overall "high-grade" appearance of the tumors, nuclei were typically rather uniform within a given example ( Fig. 2 ). Malignant cells were arranged in sheets, nests, wide trabeculae, or ribbons, and many showed a vaguely organoid growth pattern. Mitotic activity was invariably brisk, often with many more than 10 mitotic figures per 10 high-power fields. Vascular invasion was usually extensive, with tumor cells completely filling and distending vascular lumina. Severe dysplasia or carcinoma in situ was documented in the overlying mucosa in two cases. Scattered acute and chronic inflammatory cells were present in the stroma, often in areas of necrosis, but a dense lymphoid or lymphoplasmacytic infiltrate was invariably absent. By definition, tumors with glandular or squamous differentiation, syncytial growth with numerous interspersed lymphocytes, intercellular fibrils, or Homer Wright rosettes were excluded. Flexner-Wintersteiner rosettes were not seen in any cases.
In Situ Hybridization and Immunohistochemistry
Twenty-five SNUC were studied for the presence of EBV, and 22 cases had sufficient material for additional immunohistochemical stains. All cases were suitable for EBER-1 interpretation by in situ hybridization as demonstrated by some preservation of actin mRNA signal. There was no demonstrable EBER-1 expression over background levels in any case. All tumors studied were completely negative for LMP-1 (0 of 22). All tumors also were immunophenotypically negative for chromogranin, synaptophysin, CEA, and PLAP. Cases 2, 4, and 6 (3 of 22, 14%) strongly expressed CD99 (MIC-2) ( Fig. 3 ), although they lacked the characteristic membranous pattern seen in Ewing's sarcoma and peripheral primitive neuroectodermal tumors. The remaining examples of SNUC were completely negative for CD99. Four tumors showed weak staining for NSE (16%). Immunostaining for Ki-67 was negative in one case, 1+ in nine, 2+ in six, 3+ in five, and 4+ in one. Intensity of Ki-67 staining varied among the nuclei in a given tumor but was diffuse throughout the tumor within a given case (Fig. 4 ). P53 was negative in nine, 1+ in five, 2+ in two, 3+ in none, and 4+ in six (Fig. 5 ). The level of p53 protein in nonneoplastic cells was not detectable. Variably intense focal staining for EMA was present in 4 of 22 (18%).
DISCUSSION
Epidemiologic and molecular data support a causative role for EBV in the development of undifferentiated nasopharyngeal carcinoma ("lymphoepithelioma"), endemic Burkitt's lymphoma, infectious mononucleosis, posttransplantation lymphoproliferative disorder, sinonasal T-cell lymphoma, and Hodgkin's lymphoma. 9 Given the variety of tumors in the sinonasal and nasopharyngeal region associated with EBV infection, we questioned whether SNUC also might be related to EBV. The ability to detect and localize EBV in tissue sections by in situ hybridization and more recently by immunohistochemistry 21 has been extremely useful in addressing questions concerning a potential link between EBV and malignancy.
Hwang and Tsai 11 studied nasopharyngeal and sinonasal tumors for EBV RNA by in situ hybridization. Their study did not support a role for EBV in the development of sinonasal tumors, but, unlike the current series, they examined a variety of tumor types arising in the sinonasal region. Because the three remaining studies evaluating the association of EBV with carcinomas of the sinonasal region have shown controversial results, we collected the largest series of SNUC to clarify this issue. The previously largest study 15 evaluated 22 SNUC and subdivided the tumors into 11 "Western" and 11 "Asian" cases. A significant subset of Asian SNUC (7 of 11) was associated with EBV, whereas all Western cases were negative for EBV. Importantly, the Asian SNUC that showed EBV positivity were limited to those showing features similar to anaplastic large cell lymphoma, or mimicking undifferentiated nasopharyngeal carcinoma. The latter were designated as SNUC with lymphoepithelioma-like features. Sinonasal undifferentiated carcinoma of "Western" subtype showed typical morphology and were negative for EBV. Leung et al. 14 studied a variety of carcinomas arising in the sinonasal region that included one "undifferentiated" carcinoma showing EBER-1 positivity. This case involved the nasal cavity, orbit, and nasopharynx with cervical nodal metastases, and appeared histologically similar to cases interpreted as SNUC with lymphoepithelioma-like features in the study of Lopategui et al. 15 In a study by Gallo et al., 10 13 cases of SNUC were evaluated, and EBV was found in five examples. However, illustrations of the SNUC were not available, and it was not possible to correlate the positive cases with their histologic features.
The previous finding of EBV limited to those cases of so-called SNUC with unconventional morphology raises the strong possibility that this morphologic subset is distinct from true SNUC. In particular, cases designated in prior studies as "SNUC with lymphoepithelioma-like features" may, in fact, be "lymphoepithelioma-like carcinomas" arising in or secondarily involving the sinonasal region. "Lymphoepithelioma-like" carcinomas (LEC) histologically identical to so-called nasopharyngeal lymphoepithelioma may occur in a wide variety of organs. Epstein-Barr virus has been documented in LEC arising in the stomach, salivary gland, lung, and thymus. 12 Epstein-Barr virus positivity in sinonasal tumors with lymphoepithelioma-like features among Asian patients ("Asian" SNUC) suggests an ethnic proclivity to develop tumors with this morphologic pattern. The association between EBV and LEC in the salivary gland and lung also appears particularly strong in Asians, whereas the association of EBV with gastric and thymic LEC appears independent of racial background. 11 We believe that there has been confusion in the literature regarding the definition of true SNUC, and inclusion of some LEC within this group, particularly in Asian patients, accounts for purported EBV-positive "SNUC." Unlike SNUC, LEC is composed of cells with markedly vesicular nuclei, inconspicuous or absent nucleoli, indistinct cell borders creating a cytoplasmic "syncytium," and a prominent lymphoplasmacytic infiltrate (Fig. 6 , Table 2 ). The often prominent necrosis of SNUC, including comedo-like necrosis, and prominent vascular invasion, are not typical features of LEC. 6 When one excludes cases with features of LEC, the previous data do not support a relationship of SNUC and EBV. This is confirmed by our own series of 25 rigorously defined SNUC, all of which were negative for EBV EBER-1 RNA.
It is well recognized that a variety of phenotypic cell types may be present within a given tumor. Included within the category of SNUC are cases with typical morphology that show neuron-specific enolase (NSE) positivity. This immunophenotypic expression raises the possibility that these tumors represent so-called "large cell neuroendocrine carcinoma." It also could be argued that the trabecula (Fig. 7) and organoid growth patterns seen in some SNUC are light microscopic evidence in support of neuroendocrine differentiation. However, our experi-ence with far more common large cell carcinomas of the lung has indicated that these features are at best weak indicators of neuroendocrine differentiation at the immunohistochemical level and are often overtly misleading. Furthermore, they are absent from many SNUC.
A somewhat more convincing argument can be raised that SNUC with NSE positivity are large cell carcinomas with occult neuroendocrine differentiation, indicating that special techniques are required to detect neuroendocrine features. Such tumors have not been defined as an entity in the ENT system, but in the lungs they have been noted to have large nucleoli, a common feature of SNUC and a finding not attributed to tumors classically described as "neuroendocrine." 23 In the current study, we identified four SNUC with focal weak NSE reactivity that were completely negative for synaptophysin and chromogranin. Focal weak NSE positivity in the absence of other neuroendocrine antibody reactivity may possibly be attributed to the known antibody cross-specificity of NSE. 1 However, such cross-reactivity has been largely or completely eliminated with the use of monoclonal antibody preparations as those used in the current study. One previous report of SNUC and EBV with occasional NSEpositive cases did not examine other neuroendocrine markers. 10 In this study, identifying 5 of 13 SNUC positive for EBV, three SNUC were also NSE positive, but whether the NSE-positive cases were among the EBVpositive cases cannot be ascertained. 10 SNUC may show abortive neuroendocrine differentiation. In addition to occasional cases showing weak NSE staining, we documented rare neurosecretory-type granules in our original study of SNUC. 6 No evidence exists that such cases have a distinct biologic behavior. Their response to chemotherapy, in comparison with NSE-negative case, requires additional study.
Although SNUC usually consists of medium-sized cells, it may occasionally manifest as a "small blue cell FIG. 6. Typical nasopharyngeal carcinoma with a syncytial growth pattern without distinct nests, and numerous intimately associated lymphocytes. The nuclei are more variable within a given tumor than the nuclei in SNUC. tumor." We therefore were interested in the utility of CD99 for discriminating SNUC from Ewing's sarcoma/ peripheral neuroectodermal tumor (PNET) and other CD99-positive small cell lesions, including lymphoblastic lymphoma and rhabdomyosarcoma. In addition to these small cell neoplasms, a growing number of morphologically diverse proliferations has recently been identified with CD99 positivity, including myxoid solitary fibrous tumor, 18 myxoid synovial sarcoma, 13 sclerosing perineuroma, 4 leukemia cutis, 3 and calcifying aponeurotic fibroma. 5 CD99 also reacts with various normal cells such as normal granulosa and Sertoli cells. 20 The finding of occasional SNUC with strong CD99 immunostaining ( Fig. 3) indicates that this marker is not useful for discriminating SNUC from the family of CD99-positive small blue cell tumors and adds SNUC to the growing list of CD99-positive neoplasms.
Sinonasal undifferentiated carcinoma were highly variable in expression of p53 and the proliferation marker Ki-67. The number of cases studied precluded statistical significance in correlating p53 and proliferation indices with biologic parameters. However, of the cases with available follow-up, the range of p53 or Ki-67 staining was highly variable among SNUC with widely different lengths of survival (no statistically significant correlation). In fact, two SNUC with survival of 9 and 10 years showed diffuse, strong p53 positivity (one example, case 5). Although accumulation of p53 protein is usually interpreted as a surrogate marker for a mutation in the gene, elevated levels of wild-type p53 have been reported to result in a positive immunohistochemical reaction. 19 Studies at the molecular level will be necessary to further evaluate the relationship of p53 and SNUC.
Overall, cases showing strong p53 expression showed concomitant strong Ki-67, although a few cases fell outside this general observation. One case with a high level of p53 expression also showed frequent Ki-67 expression. One could hypothesize that the high proliferative index makes this particular tumor more chemoresponsive, but given the overall poor prognosis of SNUC, we do not espouse this view. We cannot fully explain the finding of some cases showing a low level of expression of Ki-67 in such a mitotically active tumor. Scrutiny of these cases indicated that these were represented by small biopsy material in which there was significant necrosis, or limited to intravascular tumor only.
The initial reports of SNUC regarded it as a malignancy with a dismal prognosis. 7 This factor, coupled with the rarity of SNUC, has resulted in few cases with long-term follow-up study. Follow-up data for the original series of cases suggested that the prognosis for patients with localized disease might be better than initially thought. 2 The current study documents three cases with extended survival (cases 7, 10, and 2). Two of these patients (cases 7 and 12) received autologous bone mar-row transplantation, and one of the transplant recipients subsequently underwent a second radical procedure to remove recurrent disease. Both of these patients survived 9 years after diagnosis but ultimately died of disease, emphasizing that 5-year disease-free survivals cannot be equated with cure for SNUC. One patient (case 10) remains free of disease 10 years after tumor resection. The median survival of patients in our study was only 18 months. This natural history is similar to the results of an earlier study that examined survival among patients with SNUC, with four of seven patients dead of disease having survived a mean of 11.5 months after therapy. 16 Although disseminated metastases were common, failure to eradicate local disease with extension into the critical adjacent tissues (e.g., brain, orbit) was the cause of death in most patients.
In summary, our findings indicate that if stringent histologic criteria are applied to the diagnosis of SNUC, then the tumor is not associated with EBV. Tumors with the appearance of a lymphoepithelioma-like carcinoma should be excluded from the category of SNUC. Sinonasal undifferentiated carcinoma may occasionally show strong CD99 positivity, and tumors show highly variable reactivity for p53 and Ki-67. Sinonasal undifferentiated carcinoma also may show abortive neuroendocrine differentiation at the immunohistochemical and ultrastructural level. This is of unknown significance. Although most patients die of disease within months, in rare instances, patients may survive for many years. 
